FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)
Cardiovascular and Renal Drugs Advisory Committee
Holiday Inn
Slides
The
committee will discuss class labeling of antihypertensive drugs based on the
proximity of their data to outcome trials
Applicable Outcomes Claims Stephen W. MacMahon, B.Sc., Ph.D., M.P.H., F.A.C.C.
For Antihypertensive Drugs Principal Director
[HTML] [PPT] Professor of Cardiovascular Medicine and Epidemiology
The George Institute for International Health
The
Differences in Outcomes Claims Stephen W. MacMahon, B.Sc., Ph.D., M.P.H., F.A.C.C.
For Different Drug Classes
Deciding Whom to Treat Jay N. Cohn, M.D.
For Hypertension Professor of Medicine and Director
[HTML] [PPT]
When to Initiate Successive Henry R. Black, M.D.
Antihypertensive Drugs Chairman and Associate Vice President for Research
[HTML] [PPT]
Can
One Sustain an Outcome
Claim Based on an Active
Controlled Study?
Introduction Lance
Berman, MD
Medical Director –
Pfizer, Inc.
Methodology and
Analysis Michael
Gaffney, Ph.D.
[Overview] Senior Director – Statistical Research and Consulting
Does
the Pattern of Blood Thomas
G. Pickering, M.D., Ph.D., F.R.C.P.
Pressure Effects During the Director – Integrative and Behavioral Cardiology Program
Day Matter? The Zena and Michael A. Wiener Cardiovascular Institute
[HTML] [PPT]
Does
the Benefit Associated with Ronald
J. Portman, M.D.
Treating Hypertension Apply to Professor of Pediatrics and Director of the Division
Children? Pediatric Nephrology and Hypertension
[HTML] [PPT]
[HTML] [PPT] Open
Public Hearing Speakers